| 5.3 -0.07 (-1.3%) | 03-06 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 9.23 | 1-year : | 10.79 |
| Resists | First : | 7.9 | Second : | 9.23 |
| Pivot price | 3.93  |
|||
| Supports | First : | 3.62 | Second : | 0.97 |
| MAs | MA(5) : | 5.17 |
MA(20) : | 3.27 |
| MA(100) : | 3.09 |
MA(250) : | 5.04 |
|
| MACD | MACD : | 0.9 |
Signal : | 0.7 |
| %K %D | K(14,3) : | 61.3 |
D(3) : | 59.2 |
| RSI | RSI(14): 66.9 |
|||
| 52-week | High : | 17.39 | Low : | 0.97 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ CDIO ] has closed below upper band by 29.4%. Bollinger Bands are 292.1% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 10 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 6.08 - 6.12 | 6.12 - 6.15 |
| Low: | 4.93 - 4.96 | 4.96 - 4.99 |
| Close: | 5.25 - 5.31 | 5.31 - 5.35 |
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.
Tue, 03 Mar 2026
10 Health Care Stocks Moving In Monday's Pre-Market Session - Sahm
Sun, 01 Mar 2026
Cardio Diagnostics to Host Investor Call on AI-Driven Cardiovascular Platform - StocksToTrade
Sun, 01 Mar 2026
Cardio Diagnostics to Highlight Strategic Growth in Upcoming Investor Call - timothysykes.com
Fri, 27 Feb 2026
Looking Into Cardio Diagnostics Holdings Inc's Recent Short Interest - Benzinga
Thu, 19 Feb 2026
Cardio Diagnostics holds investor call; furnishes presentation on clinical data, reimbursement and strategy - TradingView
Thu, 19 Feb 2026
Cardio Diagnostics Highlights Strategic Progress in Investor Update - TipRanks
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Biotechnology
|
|
| Shares Out | 0 (M) |
| Shares Float | 2 (M) |
| Held by Insiders | 1.7e+006 (%) |
| Held by Institutions | 6.7 (%) |
| Shares Short | 5 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -6.15e+006 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -59 % |
| Return on Assets (ttm) | 950.8 % |
| Return on Equity (ttm) | -61.6 % |
| Qtrly Rev. Growth | 15780 % |
| Gross Profit (p.s.) | -19.73 |
| Sales Per Share | -38.58 |
| EBITDA (p.s.) | 5498.25 |
| Qtrly Earnings Growth | -12 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -6 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | -0.14 |
| Price to Cash Flow | 3.29 |
| Dividend | 0 |
| Forward Dividend | 144490 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|